Kennedy has been most vocal about the FDA, an agency that oversees nearly $3 trillion in medicines, food and tobacco products ...
While personally “disappointed” about the election’s outcome, current FDA Commissioner Robert Califf, M.D., has laid ...
FDA commissioner Robert Califf’s second term is anticipated to end in 2025, and all eyes are now on who will be the ...
Staff turnover is typical when a new administration comes in, and a significant number of FDA employees similarly considered ...
Anxious and bewildered, some drugmakers are reaching out to their lobbyists about how Robert Kennedy’s pending nomination ...
Trump has promised he would allow Robert F. Kennedy Jr. to "go wild" on medicines, food, and health. With that, a radical antiestablishment medical movement with roots in past centuries could threaten ...
At a cancer research event Tuesday, FDA Commissioner Robert Califf said he was “disappointed” with the election results ...
Federal employees are concerned over President-elect Donald Trump’s pick, Robert F. Kennedy Jr., to lead the Department of ...
BioNTech said that it is acquiring the Chinese drugmaker Biotheus for $800 million to bolster its cancer strategy. The two ...
By Samuel Indyk and Ludwig Burger (Reuters) -Shares of major U.S. drugmakers fell on Friday after U.S. President-elect Donald ...